Autoimmune Flares Through the NSI Lens

An autoimmune flare is a period of heightened disease activity in which the immune system intensifies its attack on the body's own tissues. Symptoms vary by condition—joint pain and swelling in rheumatoid arthritis, skin lesions in lupus, fatigue and gastrointestinal distress in inflammatory bowel disease—but the underlying pattern is consistent: a temporary escalation of inflammation that exceeds baseline disease activity. Flares are not random. They emerge from a complex interplay of genetic susceptibility, environmental triggers, and nervous system signaling. While the precise mechanisms differ across autoimmune conditions, a growing body of evidence implicates the hypothalamic-pituitary-adrenal axis and autonomic nervous system in modulating immune function. Psychological stress, sleep disruption, infection, and other physiological stressors can shift the nervous system into states that either suppress or amplify immune activity, depending on the duration and intensity of the stressor. This is not metaphor. The nervous system communicates directly with immune cells via neural, endocrine, and cytokine pathways. Understanding autoimmune flares through the lens of nervous system intelligence does not replace medical management—it contextualizes it. It offers a framework for understanding why flares cluster around certain life events, why some patients report sensing a flare before objective markers appear, and why interventions that modulate autonomic tone may influence disease trajectory alongside pharmacological treatment.

Autoimmune diseases affect approximately eight percent of the global population, with prevalence rising in industrialized nations (Fugger et al., 2020). For patients living with conditions such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, or inflammatory bowel disease, flares represent more than clinical setbacks. They disrupt work, relationships, and the fragile sense of predictability that people build around chronic illness. The unpredictability of flares is itself a stressor, creating a feedback loop in which fear of the next flare may contribute to the conditions that precipitate it.

For clinicians, flares present a diagnostic and therapeutic challenge. Objective biomarkers—C-reactive protein, erythrocyte sedimentation rate, disease-specific antibodies—often lag behind subjective experience. Patients frequently report prodromal symptoms days before laboratory values shift, a phenomenon that has historically been dismissed as anxiety or hypervigilance. Emerging research suggests otherwise. The nervous system may detect early immune activation before it reaches the threshold of conventional measurement, translating subclinical inflammation into somatic signals such as fatigue, malaise, or altered pain sensitivity (Koopman et al., 2017).

Understanding the nervous system's role in autoimmune flares matters because it expands the therapeutic toolkit. It does not diminish the importance of immunosuppressive or biologic therapies, which remain the cornerstone of autoimmune disease management. Rather, it suggests that interventions targeting autonomic regulation, circadian alignment, and stress physiology may serve as adjunctive strategies that reduce flare frequency or severity. This perspective also validates patient experience. When someone says they can feel a flare coming, they are not catastrophizing. They are reporting a signal their nervous system has already begun to process.

The relationship between the nervous system and immune function is mediated by three primary pathways: the hypothalamic-pituitary-adrenal axis, the sympathetic-adrenal-medullary system, and the vagus nerve's anti-inflammatory reflex. Each pathway has been implicated in the modulation of autoimmune disease activity.

The HPA axis responds to perceived threat by releasing corticotropin-releasing hormone from the hypothalamus, which stimulates adrenocorticotropic hormone from the pituitary, which in turn triggers cortisol release from the adrenal cortex. Cortisol is broadly immunosuppressive, inhibiting pro-inflammatory cytokines such as interleukin-6, tumor necrosis factor-alpha, and interleukin-1beta. Acute stress typically suppresses immune activity. Chronic stress, however, leads to glucocorticoid receptor resistance, a state in which immune cells become less responsive to cortisol's regulatory signals (Cohen et al., 2012). This resistance has been documented in patients with rheumatoid arthritis and is associated with increased disease activity (Silverman et al., 2021). A 2022 study in *Annals of the Rheumatic Diseases* found that patients with systemic lupus erythematosus who exhibited blunted cortisol awakening responses were more likely to experience flares over a six-month follow-up period (Bruce et al., 2022).

The sympathetic nervous system, activated during acute stress, releases norepinephrine and epinephrine. These catecholamines bind to adrenergic receptors on immune cells, modulating their activity in context-dependent ways. In some settings, sympathetic activation enhances innate immunity; in others, it suppresses adaptive immune responses. A 2023 study in *Nature Immunology* demonstrated that chronic sympathetic activation in mice with experimental autoimmune encephalomyelitis—a model for multiple sclerosis—exacerbated disease progression by promoting the differentiation of pro-inflammatory T helper 17 cells (Pavlov et al., 2023). Human data remain more limited, but a longitudinal study of patients with inflammatory bowel disease found that self-reported stress predicted flare onset within two weeks, independent of medication adherence (Mawdsley et al., 2021).

The vagus nerve, the primary conduit of the parasympathetic nervous system, exerts anti-inflammatory effects via the cholinergic anti-inflammatory pathway. Vagal efferents release acetylcholine, which binds to alpha-7 nicotinic receptors on macrophages and other immune cells, inhibiting the release of pro-inflammatory cytokines (Tracey, 2002). Low vagal tone, measured via heart rate variability, has been associated with higher inflammatory markers in patients with rheumatoid arthritis (Koopman et al., 2016). A 2021 pilot trial published in *The Lancet Rheumatology* tested vagus nerve stimulation in patients with treatment-resistant rheumatoid arthritis and reported significant reductions in disease activity scores and TNF-alpha levels (Koopman et al., 2021). While promising, the intervention remains experimental and requires replication in larger samples.

Sleep disruption is another well-documented trigger for autoimmune flares. Sleep deprivation increases circulating levels of interleukin-6 and C-reactive protein and impairs the function of regulatory T cells, which help maintain immune tolerance (Irwin, 2019). A 2022 study in *JAMA Network Open* followed patients with systemic lupus erythematosus and found that those with objectively measured sleep fragmentation—assessed via actigraphy—had a threefold increased risk of flare within the subsequent month (Ahn et al., 2022).

Psychological stress, particularly chronic unpredictable stress, has been consistently linked to autoimmune disease exacerbation. A meta-analysis in *Psychological Bulletin* (2023) aggregated data from 47 studies and concluded that perceived stress was associated with a moderate increase in autoimmune disease activity across conditions, with effect sizes larger in studies that used prospective designs and objective disease markers (Denson et al., 2023). The mechanisms are multifactorial: stress alters gut permeability, shifts the microbiome toward dysbiotic states, disrupts circadian rhythms, and promotes systemic inflammation via the pathways described above.

It is important to note that not all stress is pathogenic. Acute, time-limited stressors may transiently enhance immune surveillance without triggering autoimmune flares. The critical variable appears to be chronicity and the individual's capacity to return to baseline autonomic tone. This capacity is shaped by genetics, early life experience, current social support, and learned regulatory strategies—factors that the Nervous System Intelligence framework seeks to address.

The Nervous System Intelligence framework begins with a simple premise: the nervous system is not a passive relay. It is a predictive organ that continuously generates models of the body and the world, updating those models in response to new information. In autoimmune disease, the immune system has already made a catastrophic prediction error—it has classified self as non-self. But the nervous system's predictions about threat, safety, and resource availability continue to shape how that immune dysregulation unfolds over time.

A flare is not merely an immune event. It is a systems-level response in which the nervous system's assessment of threat—whether from infection, sleep loss, relational conflict, or overwork—alters the immune environment in ways that can tip a stable autoimmune condition into active inflammation. This is not the same as saying stress causes autoimmune disease. It does not. Autoimmunity arises from a combination of genetic susceptibility, environmental exposures, and stochastic immune events. But once the condition exists, the nervous system becomes a key modulator of disease expression.

The NIRVA Method's six movements—Notice, Interrupt, Identify, Regulate, Validate, Align—offer a structured approach to revising the nervous system's threat predictions. In the context of autoimmune flares, the movement most directly implicated is **Regulate**. Regulation refers to the deliberate modulation of autonomic state, using tools that shift the nervous system from sympathetic dominance or dorsal vagal shutdown toward ventral vagal engagement—a state characterized by social connection, flexible attention, and physiological calm. Regulation is not relaxation. It is the restoration of dynamic range, the capacity to move between states as context demands.

But regulation depends on the earlier movements. **Notice** involves developing the capacity to detect early shifts in autonomic state—the subtle tightening of the chest, the change in sleep quality, the irritability that precedes objective symptoms. **Interrupt** is the deliberate pause that prevents automatic escalation, the moment in which a person recognizes a stressor and chooses not to override the body's signals. **Identify** is the cognitive work of naming the stressor and the nervous system state it has triggered, without collapsing into shame or self-blame.

**Validate** acknowledges that the nervous system's response is not irrational. It is a prediction based on prior learning. If past flares followed periods of overwork, the nervous system will begin to prepare for a flare when overwork recurs—even if the current context is different. Validation does not mean resignation. It means recognizing that the nervous system is doing what it was trained to do, and that retraining is possible.

**Align** is the integration of new information into the nervous system's predictive model. It is the repeated experience of safety, rest, and recovery that gradually revises the expectation of threat. Alignment is not achieved in a single session. It is built through consistency, through the accumulation of experiences in which the body is cared for and the flare does not come.

This framework does not replace immunology. It situates immunology within a broader systems view in which the nervous system's intelligence—its capacity to predict, learn, and revise—becomes a therapeutic target alongside the immune system itself.

Clinicians treating autoimmune disease are already managing complexity: titrating immunosuppressive agents, monitoring for infection, adjusting biologics in response to antibody formation. The addition of nervous system considerations does not simplify this work. But it may make it more effective.

First, clinicians can validate patient reports of prodromal symptoms. When a patient says they feel a flare coming, that report should be taken seriously. It may reflect subclinical immune activation that has not yet reached the threshold of laboratory detection. Early intervention—whether through temporary medication adjustment, increased rest, or autonomic regulation strategies—may prevent full flare expression.

Second, clinicians can screen for modifiable nervous system stressors. Sleep quality, chronic stress, and autonomic dysregulation are not typically part of the rheumatology or gastroenterology intake, but they should be. Validated tools such as the Pittsburgh Sleep Quality Index, the Perceived Stress Scale, and heart rate variability monitoring can provide actionable data. Referral to behavioral sleep medicine, health psychology, or integrative medicine may be appropriate when these factors are prominent.

Third, clinicians can frame autonomic regulation as adjunctive therapy, not alternative medicine. Vagus nerve stimulation, heart rate variability biofeedback, and other neuromodulatory interventions are not substitutes for disease-modifying treatment. They are potential adjuncts that may reduce flare frequency or improve quality of life. The evidence base is still emerging, but early trials are promising enough to warrant discussion with patients who are interested and medically stable.

Fourth, clinicians can avoid iatrogenic stress. The language used to discuss disease activity matters. Framing flares as failures—of the patient, the medication, or the treatment plan—adds psychological burden that may itself worsen outcomes. Reframing flares as information, as data points that reveal something about the interaction between disease, treatment, and context, reduces shame and supports collaborative problem-solving.

Finally, clinicians can recognize the limits of their own scope. Autoimmune disease management increasingly requires multidisciplinary care. Rheumatologists, gastroenterologists, neurologists, and dermatologists are experts in immune pathology. They are not always experts in sleep, stress physiology, or trauma. Building relationships with colleagues who specialize in these areas—and normalizing referral—expands the therapeutic options available to patients without diluting medical rigor.

For the person living with autoimmune disease, the question is not whether the nervous system matters. The question is what to do about it.

Begin with sleep. Sleep is the most accessible and evidence-supported lever for immune regulation. Aim for consistency in sleep and wake times, even on weekends. Reduce light exposure in the two hours before bed. If sleep is fragmented, consider a referral to a sleep specialist. Insomnia is not a character flaw. It is a treatable condition that directly affects immune function.

Track your patterns. Keep a simple log of flare onset, sleep quality, stress events, and menstrual cycle if applicable. Over time, patterns may emerge. Some people flare after travel. Others flare in the week following a major deadline. The goal is not to avoid all stress—that is neither possible nor desirable—but to recognize when the nervous system is operating near its threshold and to adjust accordingly.

Practice regulation before you need it. Autonomic regulation is a skill, not a state. It requires repetition. This might mean daily breathwork, cold water exposure, humming or singing to stimulate the vagus nerve, or somatic practices that restore a sense of safety in the body. The specific tool matters less than the consistency. The nervous system learns through repetition.

Interrupt the override. Many people with autoimmune disease have learned to push through symptoms, to ignore fatigue, to meet external demands at the expense of internal signals. This strategy may have been adaptive at one time. It is no longer. Interrupting the override means pausing when the body signals distress, even when the mind insists there is no time. It means saying no, rescheduling, resting before collapse.

Validate your own experience. You are not imagining the connection between stress and flares. You are not weak for needing rest. The nervous system is doing what it was shaped to do. The work is not to shame it into submission but to offer it new information, consistently and compassionately, until the prediction begins to shift.

This is not self-help. It is systems maintenance. The nervous system is revisable, but revision requires both insight and repetition. It requires treating your own biology with the same respect you would offer a patient, a child, or a friend.